This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kolb HJ . Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008; 112: 4371–4383.
Spierings E, Goulmy E . Expanding the immunotherapeutic potential of minor histocompatibility antigens. J Clin Invest 2005; 115: 3397–3400.
Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1 or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742–2747.
Gallardo D, Aróstegui JI, Balas A, Torres A, Caballero D, Carreras E et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001; 114: 931–936.
Lin MT, Gooley T, Hansen JA, Tseng LH, Martin EG, Singleton K et al. Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation. Blood 2001; 98: 3172–3173.
Pérez-García A, De la Cámara R, Torres A, González M, Jiménez A, Gallardo D . Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation. Haematologica 2005; 90: 1723–1724.
Gallardo D, Pérez-García A, de la Cámara R, Iriondo A, Jiménez-Velasco A, Torres A et al. Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell source. Leukemia 2006; 20: 1461–1464.
Oostvogels R, Minnema MC, van Elk M, Spaapen RM, te Raa GD, Giovannone B et al. Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1. Leukemia 2013; 27: 642–649.
Spierings E, Drabbels J, Hendriks M, Pool J, Spruyt-Gerritse M, Claas F et al. A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. PLoS One 2006; 1: e42.
Spierings E, Kim YH, Hendriks M, Borst E, Sergeant R, Canossi A et al. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013; 19: 1244–1253.
Acknowledgements
This work has been partially financed by grant FIS11/01690 from the Fondo de investigaciones sanitarias, Health Ministery of Spain, and by grant MTV3/120210 from Fundació Marató TV3. We are also grateful for the financial support given by the association ‘Llavaneres contra el càncer’.
Author contributions
AB-V and DG performed the statistical analysis and wrote the letter; RR-R, GO-G and AB-V performed the laboratory work; JBN, RC, SB, CV, CM-L, IB, AU-I, MG and AJ-V recruited the samples and the clinical information.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interests.
Rights and permissions
About this article
Cite this article
Bosch-Vizcaya, A., Rodriguez-Romanos, R., Nieto, J. et al. Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT. Bone Marrow Transplant 50, 298–300 (2015). https://doi.org/10.1038/bmt.2014.234
Published:
Issue date:
DOI: https://doi.org/10.1038/bmt.2014.234